Anxiety and ketamine research
What current research says about anxiety disorders, established therapies, and the limited but evolving evidence around ketamine.
Overview
Anxiety disorders include generalized anxiety disorder, social anxiety, panic disorder, and others. They are common, treatable, and frequently respond well to structured psychological care combined with — in some cases — medication.
Conventional treatment
Cognitive behavioral therapy (CBT) and exposure-based therapies have strong evidence across anxiety disorders. SSRIs and SNRIs are commonly used first-line medications. Benzodiazepines are generally avoided for long-term use due to dependence and tolerance concerns.
Where ketamine fits
Research into ketamine for anxiety is earlier-stage than for depression and PTSD. Some small trials suggest short-term reductions in anxiety symptoms, particularly when anxiety co-occurs with depression, but the evidence base is still developing.
What current evidence suggests
Most rigorous studies of ketamine in anxiety focus on co-occurring depression or specific subgroups. Effect sizes, durability, and ideal protocols remain active research questions.
Frequently asked questions
Is ketamine effective for generalized anxiety?+
Evidence is preliminary. Some studies show short-term symptom reduction, but ketamine is not currently considered a first-line treatment for generalized anxiety disorder.
What is first-line care for anxiety?+
Cognitive behavioral therapy, exposure-based approaches, and SSRIs or SNRIs are well-supported by evidence and typically tried first.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.